Gene expression profile of HIV-1 Tat expressing cells: A close interplaybetween proliferative and differentiation signals

BMC Biochemistry

Volumn 3, Issue , 2002, Pages 1-22

  De La Fuente, Cynthia ^b   Santiago, Francisco ^b   Deng, Longwen ^b   Eadie, Carolyne ^b   Zilberman, Irene ^b   Kehn, Kylene ^b   Maddukuri, Anil ^b   Baylor, Shanese ^b   Wu, Kaili ^b   Lee, Chee Gun ^a   Pumfery, Anne ^b   Kashanchi, Fatah ^b  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE ACETYLTRANSFERASE PCAF; HORMONE RECEPTOR; PROTEIN TYROSINE KINASE; RAF PROTEIN; RAS PROTEIN; THYMOSIN; TRANSACTIVATOR PROTEIN; TYROSINE KINASE RECEPTOR;

ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CHROMATIN STRUCTURE; DNA MICROARRAY; DOWN REGULATION; ENZYME ACTIVITY; GENE EXPRESSION PROFILING; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA TRANSLATION; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; UNINDEXED SEQUENCE; VIRUS ACTIVATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 33745182034     PISSN: 14712091     EISSN: None     Source Type: Journal    
DOI: 10.1186/1471-2091-3-14     Document Type: Article

References (103)

1. Schena M, Shalon D, Davis RW and Brown PO Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 1995, 270:467-470
2. Lockhart DJ, Dong H, Byrne MC, Follettie MT, Gallo MV, Chee MS, Mittmann M, Wang C, Kobayashi M, Horton H and Brown EL Expression monitoring by hybridization to high-density oligonucleotide arrays. Nat Biotechnol. 1996, 14:1675-1680
3. Perou CM, Jeffrey SS, van de Rijn M, Rees CA, Eisen MB, Ross DT, Pergamenschikov A, Williams CF, Zhu SX, Lee JC, Lashkari D, Shalon D, Brown PO and Botstein D Distinctive gene expression patterns in human mammary epithelial cells and breast cancers. Proc Natl Acad Sci U S A 1999, 96:9212-9217
4. Golub TR, Slonim DK, Tamayo P, Huard C, Gaasenbeek M, Mesirov JP, Coller H, Loh ML, Downing JR, Caligiuri MA, Bloomfield CD and Lander ES Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 1999, 286:531-537
5. Alizadeh AA and Staudt LM Genomicscale gene expression profiling of normal and malignant immune cells. Curr Opin Immunol. 2000, 12:219-225
6. DeRisi JL, Iyer VR and Brown PO Exploring the metabolic and genetic control of gene expression on a genomic scale. Science 1997, 278:680-686
7. Eisen A and Lucchesi JC Unraveling the role of helicases in transcription. Bioessays 1998, 20:634-641
8. Gray IC, Stewart LM, Phillips SM, Hamilton JA, Gray NE, Watson GJ, Spurr NK and Snary D Mutation and expression analysis of the putative prostate tumour-suppressor gene PTEN. Br J Cancer. 1998, 78:1296-1300
9. Holstege FC, Jennings EG, Wyrick JJ, Lee TI, Hengartner CJ, Green MR, Golub TR, Lander ES and Young RA Dissecting the regulatorycircuitry of a eukaryotic genome. Cell 1998, 95:717-728
10. Marton MJ, DeRisi JL, Bennett HA, Iyer VR, Meyer MR, Roberts CJ, Stoughton R, Burchard J, Slade D, Dai H, Bassett DE Jr, Hartwell LH, Brown PO and Friend SH Drug target validation and identification of secondary drug target effects using DNA microarrays. Nat Med 1998, 4:1293-1301
11. Roberts CJ, Nelson B, Marton MJ, Stoughton R, Meyer MR, Bennett HA, He YD, Dai H, Walker WL, Hughes TR, Tyers M, Boone C and Friend SH Signaling and circuitry of multiple MAPK pathways revealed by a matrix of global gene expression profiles. Science 2000, 287:873-880
12. Kamp W, Berk MB, Visser CJ and Nottet HS Mechanisms of HIV-1 to escape from the host immune surveillance. Eur J Clin Invest 2000, 30:740-746
13. Verhoef K, Bauer M, Meyerhans A and Berkhout B On the role of the second coding exon of the HIV-1 Tat protein in virus replication and MHC class I downregulation. AIDS Res Hum Retroviruses 1998, 14:1553-1559
14. Willard-Gallo KE, Furtado M, Burny A and Wolinsky SM Down-modulation of TCR/CD3 surface complexes after HIV-1 infection is associated with differential expression of the viral regulatory genes. Eur J Immunol 2001, 31:969-979
15. Caldwell RL, Egan BS and Shepherd VL HIV-1 Tat represses transcription from the mannose receptor promoter. J Immunol 2000, 165:7035-7041
16. Dragoni I, Mariotti M, Consalez GG, Soria MR and Maier JA EDF-1, a novel gene product down-regulated in human endothelial cell differentiation. J Biol Chem 1998, 273:31119-311124
17. Venanzi S, Destree OH, Gigliani F and Battaglia PA Analysis of HIV-1 Tat effects in Xenopus laevis embryos. J Biomed Sci 1998, 5: 211-220
18. Duan L, Ozaki I, Oakes JW, Taylor JP, Khalili K and Pomerantz RJ The tumor suppressor protein p53 strongly alters human immunodeficiency virus type 1 replication. J Virol 1994, 68:4302-4313
19. Li J, Wang C, Friedman DJ and Pardee AB Reciprocal modulations between p53 and Tat of human immunodeficiency virus type 1. Proc Natl Acad Sci U S A 1995, 92:5461-5464
20. Clark E, Santiago F, Deng L, Chong S, de La Fuente C, Wang L, Fu P, Stein D, Denny T, Lanka V, Mozafari F, Okamoto T and Kashanchi F Loss of G(1)/S checkpoint in human immunodeficiency virus type 1-infected cells is associated with a lack of cyclin-dependent kinase inhibitor p21/Waf1. J Virol 2000, 74:5040-5052
21. Longo F, Marchetti MA, Castagnoli L, Battaglia PA and Gigliani F A novel approach to proteinprotein interaction: complex formation between the p53 tumor suppressor and the HIV Tat proteins. Biochem. Biophys. Res. Commun. 1995, 206:326-334
22. Roy S, Katze MG, Parkin NT, Edery I, Hovanessian AG and Sonenberg N Control of the interferon-induced 68-kilodalton protein kinase by the HIV-1 tat gene product. Science 1990, 247:1216-1219
23. Zauli G, Secchiero P, Rodella L, Gibellini D, Mirandola P, Mazzoni M, Milani D, Dowd DR, Capitani S and Vitale M HIV-1 Tat-mediated inhibition of the tyrosine hydroxylase gene expression in dopaminergic neuronal cells. J Biol Chem 2000, 275:4159-4165
24. Weissman JD, Brown JA, Howcroft TK, Hwang J, Chawla A, Roche PA, Schiltz L, Nakatani Y and Singer DS HIV-1 tat binds TAFII250 and represses TAFII250-dependent transcription of major histocompatibility class I genes. Proc Natl Acad Sci U S A. 1998, 95:11601-11606
25. Creaven M, Hans F, Mutskov V, Col E, Caron C, Dimitrov S and Khochbin S Control of the histone-acetyltransferase activity of Tip60 by the HIV-1 transactivator protein, Tat. Biochemistry 1999, 38:8826-8830
26. de La Fuente C, Deng L, Santiago F, Arce L, Wang L and Kashanchi F Gene expression array of HTLV type 1 infected T cells: Up-regulation of transcription factors and cell cycle genes. AIDS Res Hum Retroviruses 2000, 16:1695-1700
27. Xiao H, Neuveut C, Tiffany HL, Benkirane M, Rich EA, Murphy PM and Jeang KT Selective CXCR4 antagonism by Tat: implications for in vivo expansion of coreceptor use by HIV-1. Proc Natl Acad Sci U S A 2000, 97:11466-11471
28. Secchiero P, Zella D, Capitani S, Gallo RC and Zauli G Extracellular HIV-1 tat protein up-regulates the expression of surface CXC-chemokine receptor 4 in resting CD4+ T cells. J Immunol 1999, 162:2427-2431
29. Bisgaard H Role of leukotrienes in asthma pathophysiology. Pediatr Pulmonol 2000, 30:166-176
30. Martin V, Ronde P, Unett D, Wong A, Hoffman TL, Edinger AL, Doms RW and Funk CD Leukotriene binding, signaling, and analysis of HIV coreceptor function in mouse and human leukotriene B4 receptor-transfected cells. J Biol Chem 1999, 274:8597-8603
31. Owman C, Garzino-Demo A, Cocchi F, Popovic M, Sabirsh A and Gallo RC The leukotriene B4 receptor functions as a novel type of coreceptor mediating entry of primary HIV-1 isolates into CD4-positive cells. Proc Natl Acad Sci 1998, 95:9530-9534
32. Speth C, Pichler I, Stockl G, Mair M and Dierich MP Urokinase plasminogen activator receptor (uPAR; CD87) expression on monocytic cells and T cells is modulated by HIV-1 infection. Immunobiology 1998, 199:152-162
33. Harnick DJ, Jayaraman T, Ma Y, Mulieri P, Go LO and Marks AR The human type 1 inositol 1,4,5-trisphosphate receptor from T lymphocytes. Structure, localization, and tyrosine phosphorylation. J Biol Chem 1995, 270:2833-2840
34. Mayne M, Holden CP, Nath A and Geiger JD Release of calcium from inositol 1,4,5-trisphosphate receptor-regulated stores by HIV-1 Tat regulates TNF-alpha production in human macrophages. J Immunol 2000, 164:6538-6542
35. Everall IP, Hudson L, al-Sarraj S, Honavar M, Lantos P and Kerwin R Decreased expression of AMPA receptor messenger RNA and protein in AIDS: a model for HIV-associated neurotoxicity. Nat Med 1995, 1:1174-1178
36. Kustova Y, Espey MG, Sei Y and Basile AS Regional decreases [corrected] in AMPA receptor density in mice infected with the LP-BM5 murine leukemia virus. Neuroreport 1997, 8:2410
37. Zhang B, MacNaul K, Szalkowski D, Li Z, Berger J and Moller DE Inhibition of adipocyte differentiation by HIV protease inhibitors. J Clin Endocrinol Metab 1999, 84:4274-4277
38. Carr A HIV protease inhibitor-related lipodystrophy syndrome. Clin Infect Dis 2000, 30:S135-S142
39. Greco A, Bienvenut W, Sanchez JC, Kindbeiter K, Hochstrasser D, Madjar JJ and Diaz JJ Identification of ribosomeassociated viral and cellular basic proteins during the course of infection with herpes simplex virus type 1. Proteomics 2001, 1:545-549
40. Dimitrov DS and Martin MA HIV results in the frame. CD4+ cell turnover. Nature 1995, 375:194-195
41. Choudhury I, Wang J, Stein S, Rabson A and Leibowitz MJ Translational effects of peptide antagonists of Tat protein of human immunodeficiency virus type 1. J Gen Virol 1999, 80:777-782
42. Irvine JH, horsfield JA, McKinney CZ and Tate WP A novel strategy to interfere with human immunodeficiency virus type 1 propogation. NZ Med J 1998, 111:222-224
43. Buck CB, Shen X, Egan MA, Pierson TC, Walker CM and Siliciano RF The human immunodeficiency virus type 1 gag gene encodes an internal ribosome entry site. J Virol 2001, 75:181-191
44. Kozak M Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes. Cell. 1986, 44:283-292
45. Parkin NT, Cohen EA, Darveau A, Rosen C, Haseltine W and Sonenberg N Mutational analysis of the 5′ non-coding region of human immunodeficiency virus type 1: effects of secondary structure on translation. EMBO J. 1988, 7:2831-2837
46. SenGupta DN, Berkhout B, Gatignol A, Zhou AM and Silverman RH Direct evidence for translational regulation by leader RNA and Tat protein of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci 1990, 87:7492-7496
47. Chen CY and Sarnow P Initiation of protein synthesis by the eukaryotic translational apparatus on circular RNAs. Science. 1995, 268:415-417
48. Cornelis S, Bruynooghe Y, Denecker G, Van Huffel S, Tinton S and Beyaert R Identification and characterization of a novel cell cycle-regulated internal ribosome entry site. Mol. Cell. 2000, 5: 597-605
49. Bonneau AM and Sonenberg N Involvement of the 24-kDa cap-binding protein in regulation of protein synthesis in mitosis. J. Biol. Chem. 1987, 262:11134-11139
50. Vagner S, Waysbort A, Marenda M, Gensac MC, Amalric F and Prats AC Alternative translation initiation of the Moloney murine leukemia virus mRNA controlled by internal ribosome entry involving the p57/PTB splicing factor. J. Biol. Chem. 1995, 270:20376-20383
51. Cullen BR HIV-1 auxiliary proteins: making connections in a dying cell. Cell. 1998, 93:685-692
52. Marshall MS Ras target proteins in eukaryotic cells. FASEB J. 1995, 9:1311-1318
53. Lewis TS, Shapiro PS and Ahn NG Signal transduction through MAP kinase cascades. Adv Cancer Res 1998, 74:49-139
54. McCubrey JA, May WS, Duronio V and Mufson A Serine/threonine phosphorylation in cytokine signal transduction. Leukemia 2000, 14:9-21
55. Bonni A, Brunet A, West AE, Datta SR, Takasu MA and Greenberg ME Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms. Science. 1999, 286:1358-1362
56. Kwon EM, Raines MA, Blenis J and Sakamoto KM Granulocyte-macrophage colony-stimulating factor stimulation results in phosphorylation of cAMP response element-binding protein through activation of pp90RSK. Blood. 2000, 95:2552-2558
57. Wu Z, Cavallaro U, Marchisio PC, Soria MR and Maier JA Fibronectin modulates the effects of HIV-1 Tat on the growth of murine Kaposi's sarcoma-like cells through the down-regulation of tyrosine phosphorylation. Am J Pathol 1998, 152:1599-1605
58. Jia H, Lohr M, Jezequel S, Davis D, Shaikh S, Selwood D and Zachary I Cysteine-rich and basic domain HIV-1 Tat peptides inhibit angiogenesis and induce endothelial cell apoptosis. Biochem Biophys Res Commun 2001, 283:469-479
59. Kusdra L, McGuire D and Pulliam L Changes in monocyte/macrophage neurotoxicity in the era of HAART: implications for HIV-associated dementia. AIDS 2002, 16:31-38
60. Yang X, Chen Y and Gabuzda D ERK MAP kinase links cytokine signals to activation of latent HIV-1 infection by stimulating a cooperative interaction of AP-1 and NF-kappaB. J Biol Chem 1999, 274:27981-27988
61. Yang X and Gabuzda D Regulation of human immunodeficiency virus type 1 infectivity by the ERK mitogen-activated protein kinase signaling pathway. J Virol 1999, 73:3460-3466
62. Jacque JM, Mann A, Enslen H, Sharova N, Brichacek B, Davis RJ and Stevenson M Modulation of HIV-1 infectivity by MAPK, a virion-associated kinase. EMBO J 1998, 17:2607-2618
63. Eckert K, Grunberg E, Immenschuh P, Garbin F, Kreuser ED and Maurer HR Interleukin-2-activated killer cell activity in colorectal tumor patients: evaluation of in vitro effects by prothymosin alpha1. J Cancer Res Clin Oncol. 1997, 123:420-428
64. Sburlati AR, Manrow RE and Berger SL Prothymosin alpha anti-sense oligomers inhibit myeloma cell division. Proc Natl Acad Sci U S A 1991, 88:253-257
65. Eschenfeldt WH, Manrow RE, Krug MS and Berger SL Isolation and partial sequencing of the human prothymosin alpha gene family. Evidence against export of the gene products. J Biol Chem. 1989, 264:7546-7555
66. Szabo P, Panneerselvam C, Clinton M, Frangou-Lazaridis M, Weksler D, Whittington E, Macera MJ, Grzeschik KH, Selvakumar A and Horecker BL Prothymosin alpha gene in humans: organization of its promoter region and localization to chromosome 2. Hum Genet. 1993, 90:629-634
67. Tsitsiloni OE, Stiakakis J, Koutselinis A, Gogas J, Markopoulos C, Yialouris P, Bekris S, Panoussopoulos D, Kiortsis V, Voelter W and Haritos AA Expression of alpha-thymosins in human tissues in normal and abnormal growth. Proc Natl Acad Sci U S A. 1993, 90:9504-9507
68. Dominguez F, Magdalena C, Cancio E, Roson E, Paredes J, Loidi L, Zalvide J, Fraga M, Forteza J and Regueiro BJ Tissue concentrations of prothymosin alpha: a novel proliferation index of primary breast cancer. Eur J Cancer. 1993, 29:893-897
69. Wu CG, Habib NA, Mitry RR, Reitsma PH, van Deventer SJ and Chamuleau RA Overexpression of hepatic prothymosin alpha, a novel marker for human hepatocellular carcinoma. Br J Cancer. 1997, 76:1199-1204
70. Sasaki H, Fujii Y, Masaoka A, Yamakawa Y, Fukai I, Kiriyama M, Saito Y and Matsui H Elevated plasma thymosin-alpha1 levels in lung cancer patients. Eur J Cardiothorac Surg. 1997, 12:885-891
71. Vareli K, Tsolas O and Frangou-Lazaridis M Regulation of prothymosin alpha during the cell cycle. Eur J Biochem. 1996, 238:799-806
72. Papamarcaki T and Tsolas O Prothymosin alpha binds to histone H1 in vitro. Papamarcaki T, Tsolas O: FEBS Lett. 1994, 345:71-75
73. Karetsou Z, Sandaltzopoulos R, Frangou-Lazaridis M, Lai CY, Tsolas O, Becker PB and Papamarcaki T Prothymosin alpha modulates the interaction of histone H1 with chromatin. Nucleic Acids Res. 1998, 26:3111-3118
74. Gomez-Marquez J and Rodriguez P Prothymosin alpha is a chromatin-remodelling protein in mammalian cells. Biochem J. 1998, 333:1-3
75. Caligiuri M, Connolly T and Beach D Ran1 functions to control the Cdc10/Sct1 complex through Puc1. Mol Biol Cell 1997, 8:1117-1128
76. Stepanova L, Finegold M, DeMayo F, Schmidt EV and Harper JW The oncoprotein kinase chaperone CDC37 functions as an oncogene inmice and collaborates with both c-myc and cyclin D1 in transformation of multiple tissues. Mol Cell Biol 2000, 20:4462-4473
77. Mahony D, Parry DA and Lees E Active cdk6 complexes are predominantly nuclear and represent only a minority of the cdk6 in T cells. Oncogene 1998, 16:603-611
78. Dai K, Kobayashi R and Beach D Physical interaction of mammalian CDC37 with CDK4. J Biol Chem 1996, 271:22030-22034
79. Moorthamer M, Panchal M, Greenhalf W and Chaudhuri B The p16(INK4A) protein and flavopiridol restore yeast cell growth inhibited by Cdk4. Biochem Biophys Res Commun 1998, 250:791-797
80. Farrell A and Morgan DO Cdc37 promotes the stability of protein kinases Cdc28 and Cak1. Mol Cell Biol 2000, 20:749-754
81. O'Keeffe B, Fong Y, Chen D, Zhou S and Zhou Q Requirement for a kinase-specific chaperone pathway in the production of a Cdk9/cyclin T1 heterodimer responsible for P-TEFb-mediated tat stimulation of HIV-1 transcription. J Biol Chem 2000, 275:279-287
82. Struhl K Histone acetylation and transcriptional regulatory mechanisms. Genes Dev. 1998, 12:599-606
83. Kadonaga JT Eukaryotic transcription: an interlaced network of transcription factors and chromatin-modifying machines. Cell 1998, 92:307-313
84. Heinzel T, Lavinsky RM, Mullen TM, Soderstrom M, Laherty CD, Torchia J, Yang WM, Brard G, Ngo SD, Davie JR, Seto E, Eisenman RN, Rose DW, Glass CK and Rosenfeld MG A complex containing N-CoR, mSin3 and histone deacetylase mediates transcriptional repression. Nature 1997, 387:43-48
85. Nagy L, Kao HY, Chakravarti D, Lin RJ, Hassig CA, Ayer DE, Schreiber SL and Evans RM Nuclear receptor repression mediated by a complex containing SMRT, mSin3A, and histone deacetylase. Cell 1997, 89:373-380
86. Xu L, Lavinsky RM, Dasen JS, Flynn SE, McInerney EM, Mullen TM, Heinzel T, D Szeto, Korzus E, Kurokawa R, Aggarwal AK, Rose DW, Glass CK and Rosenfeld MG Signal-specific co-activator domain requirements for Pit-1 activation. Nature 1998, 395:301-306
87. Xu L, Glass CK and Rosenfeld MG Coactivator and corepressor complexes in nuclear receptor function. Curr Opin Genet Dev 1999, 9:140-147
88. Brinkmann AO Steroid hormone receptors: activators of gene transcription. J Pediatr Endocrinol 1994, 7:275-282
89. Leo C and Chen JD The SRC family of nuclear receptor coactivators. Gene 2000, 245:1-11
90. Shikama N, Lyon J and LaThangue NB The p300/CBP family: Intergrating signals with transcription factors and chromatin. Trends Cell Biol 1997, 7:230-236
91. Yao TP, Oh SP, Fuchs M, Zhou ND, Ch'ng LE, Newsome D, Bronson RT, Li E, Livingston DM and Eckner R Gene dosage-dependent embryonic development and proliferation defects in mice lacking the transcriptional integrator p300. Cell 1998, 93:361-372
92. Kawasaki H, Eckner R, Yao TP, Taira K, Chiu R, Livingston DM and Yokoyama KK Distinct roles of the co-activators p300 and CBP in retinoic-acid-induced F9-cell differentiation. Nature 1998, 393:284-289
93. Kraus WL and Kadonaga JT p300 and estrogen receptor cooperatively activate transcription via differential enhancement of initiation and reinitiation. Genes Dev. 1998, 12:331-342
94. Hong H, Kohli K, Garabedian MJ and Stallcup MR GRIP1, a transcriptional coactivator for the AF-2 transactivation domain of steroid, thyroid, retinoid, and vitamin D receptors. Mol Cell Biol. 1997, 17:2735-2744
95. Voegel JJ, Heine MJ, Tini M, Vivat V, Chambon P and Gronemeyer H The coactivator TIF2 contains three nuclear receptor-binding motifs and mediates transactivation through CBP binding-dependent and -independent pathways. EMBO J. 1998, 17:507-519
96. Torchia J, Rose DW, Inostroza J, Kamei Y, Westin S, Glass CK and Rosenfeld MG The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function. Nature 1997, 387:677-684
97. Chen H, Lin RJ, Schiltz RL, Chakravarti D, Nash A, Nagy L, Privalsky ML, Nakatani Y and Evans RM Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300. Cell 1997, 90:569-580
98. Anzick SL, Kononen J, Walker RL, Azorsa DO, Tanner MM, Guan XY, Sauter G, Kallioniemi OP, Trent JM and Meltzer PS AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer. Science 1997, 277:965-968
99. Spencer TE, Jenster G, Burcin MM, Allis CD, Zhou J, Mizzen CA, McKenna NJ, Onate SA, Tsai SY, Tsai MJ and O'Malley BW Steroid receptor coactivator-1 is a histone acetyltransferase. Nature 1997, 389:194-198
100. Heery DM, Kalkhoven E, Hoare S and Parker MG A signature motif in transcriptional co-activators mediates binding to nuclear receptors. Nature 1997, 387:733-736
101. McInerney EM, Rose DW, Flynn SE, Westin S, Mullen TM, Krones A, Inostroza J, Torchia J, Nolte RT, Assa-Munt N, Milburn MV, Glass CK and Rosenfeld MG Determinants of coactivator LXXLL motif specificity in nuclear receptor transcriptional activation. Genes Dev 1998, 12:3357-3368
102. Kutsch O, Oh J, Nath A and Benveniste EN Induction of the chemokines interleukin-8 and IP-10 by human immunodeficiency virus type 1 Tat in astrocytes. J Virol. 2000, 74:9214-9221
103. Mahieux R, Lambert PF, Agbottah E, Halanski MA, Deng L, Kashanchi F and Brady JN Cell cycle regulation of human interleukin-8 gene expression by the human immunodeficiency virus type 1 Tat protein. J Virol 2001, 75:1736-1743